Category Archives: Doctrine of equivalents

Mylan Insitutional LLC and Apicore US LLC v. Aurobindo Pharma Ltd., et al.

Docket No. 2017-1645 LOURIE, MOORE, REYNA May 19, 2017 Brief Summary: DC grant of preliminary injunction and finding of infringement Apicore’s “process patents” under the DOE reversed since the function-way-result test not appropriate under this chemical case. Grant of PI … Continue reading

Posted in Anticipation (35 USC 102), Doctrine of equivalents, Infringement, Obviousness | Leave a comment

Tomita Technologies USA, LLC et al. v. Nintendo Co., Ltd.

Docket No. 2016-2015 PROST, BRYSON, WALLACH March 17, 2017 Non-precedential Brief Summary: DC finding of no infringement of means-plus-function limitation after consideration of “function-way-result” and “insubstantial differences” tests affirmed. Summary: Tomita appealed DC holding on remand (Tomita Techs., FC 2014) … Continue reading

Posted in Doctrine of equivalents, Infringement, Means-plus-function | Leave a comment

Power Integrations, Inc. v. Fairchild Semiconductor Int., Inc. et al.

Docket No. 2015-1329, -1388 PROST, SCHALL, CHEN December 12, 2016 Brief Summary: Opinion addresses several grounds of appeal and cross-appeal in a long-running dispute (see, e.g., Power Int., FC 2015 and 2013) relating to the power supply controller chip market … Continue reading

Posted in Anticipation (35 USC 102), Claim Vitiation, Doctrine of equivalents, Inducement to Infringe, Infringement, Obviousness | Leave a comment

David Netzer Consulting Engineer LLC v. Shell Oil Company et al.

Docket No. 2015-2086 PROST, LOURIE, TARANTO May 27, 2016 Brief Summary: DC claim construction and grant of SJ of no infringement affirmed based on that construction. Summary: Netzer appealed DC grant of SJ of noninfringement of US 6,667,496 to Shell. … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Prosecution History Estoppel | Leave a comment

Intendis GmbH, et al. (Bayer) v. Glenmark Pharmaceuticsl Inc., USA et al.

Docket No. 2015-1902 PROST, MOORE, TARANTO May 16, 2016 Brief Summary: DC finding that Glenmark’s proposed generic (ANDA) version of Fincaea® Gel for treatment of rosacea infringed claims 1-12 of US 6,534,070 under the doctrine of equivalents (DOE) and were … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Obviousness | Leave a comment

Howmedica Osteonics Corp., Stryker Ireland Ltd. v. Zimmer, Inc., Wright Medical Technology, Inc., Smith & Nephew, Inc.

Docket No. 2015-1232, -1234, -1239 O’MALLEY, PLAGER, WALLACH May 12, 2016 Brief Summary: DC claim construction (“there is a fine line between reading a claim in light of the written description and reading a limitation into the claim from” it), … Continue reading

Posted in Claim Construction, Claim Differentiation, Doctrine of equivalents, Written description | Leave a comment

Akzo Nobel Coatings, Inc. v. Dow Chemical Company

Docket Nos. 2015-1331, 2015-1389 LOURIE, REYNA, CHEN January 29, 2016 Brief Summary: DC grant of SJ to Dow of non-infringement literally or under DOE affirmed. DC findings of no indefiniteness also affirmed. Summary: Akzo appealed DC grant of SJ to … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Indefiniteness, Infringement | Leave a comment